In vivo experiments demonstrate that suppressing HIF-1α protein expression reduces the growth rate of subcutaneously formed tumors and decreases the expression levels of proteins associated with the P-PI3K/P-AKT, SOX2/OCT4, and MMP2/MMP9 pathways within the tumor. The gene discussed is MMP9; the disease is neoplasm.